Mesenchymal Cell News Volume 16.16 | Apr 30 2024

    0
    4







    2024-04-30 | MESCN 16.16


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 16.16 – 30 April, 2024
    TOP STORY

    Emx2 Underlies the Development and Evolution of Marsupial Gliding Membranes

    By combining epigenomics, transcriptomics, and in-pouch marsupial transgenics, scientists showed that Emx2 was a critical upstream regulator of patagium development.
    [Nature]

    Full ArticlePress Release
    Win a Hippocampus Print! Sign up for the StainsFile Newsletter to enter the draw.
    PUBLICATIONSRanked by the impact factor of the journal

    Hematopoietic Stem Cell Niche Generation and Maintenance Are Distinguishable by an Epitranscriptomic Program

    Investigators compared perinatal and adult bone marrow MSCs. MSCs exhibited enrichment in genes mediating m6A mRNA methylation at the perinatal stage and downregulated the expression of Mettl3 shortly after birth.
    [Cell]

    AbstractGraphical Abstract

    Nonlinear Elastic Bottlebrush Polymer Hydrogels Modulate Actomyosin Mediated Protrusion Formation in Mesenchymal Stromal Cells

    Bottlebrush polymers were synthesized and crosslinked to form poly(ethylene glycol)-based hydrogels and used to study how strain-stiffening behavior affects human MSCs.
    [Advanced Materials]

    Abstract

    Mesenchymal Stromal/Stem Cells Promote Intestinal Epithelium Regeneration after Chemotherapy-Induced Damage

    Single cell human small intestine organoids were embedded in Matrigel, grown for five days and treated with busulfan for 48 hours.
    [Stem Cell Research & Therapy]

    Full Article

    rhBMP-2 Induces Terminal Differentiation of Human Bone Marrow Mesenchymal Stromal Cells Only by Synergizing with Other Signals

    Recombinant human bone morphogenetic protein 2 (rhBMP-2) and human bone marrow MSCs were tested in an in vivo subcutaneous implantation model to assess their ability to form mature bone and undergo multilineage differentiation.
    [Stem Cell Research & Therapy]

    Full Article

    HOXB5 Promotes the Progression and Metastasis of Osteosarcoma Cells by Activating the JAK2/STAT3 Signaling Pathway

    The expression of homeobox gene B5 (HOXB5) in human osteosarcoma tissues and its correlation with clinical indicators were investigated using bioinformatics analysis and immunohistochemical labelling.
    [Heliyon]

    Full Article

    In Vitro Anti-leukemic Effect of Wharton’s Jelly Derived Mesenchymal Stem Cells

    Wharton’s Jelly-derived-MSCs were isolated from human umbilical cord. The cells were incubated according to the standard culture conditions and characterized by flow cytometry.
    [Molecular Biology Reports]

    Abstract

    Design of a Stem Cell–Based Therapy for Ependymal Repair in Hydrocephalus Associated with Germinal Matrix Hemorrhages

    Investigators explored the possibilities of ependymal repair in germinal matrix hemorrhage/posthemorrhagic hydrocephalus using a combination of neural stem cells, ependymal progenitors, and mesenchymal stem cells.
    [Stroke]

    Full ArticleGraphical Abstract

    Oncogene-Induced Matrix Reorganization Controls CD8+ T Cell Function in the Soft-Tissue Sarcoma Microenvironment

    Scientists investigated how extracellular matrix composition modulated CD8+ T cell function in undifferentiated pleomorphic sarcoma, an immunologically active desmoplastic tumor.
    [European Journal Of Clinical Investigation]

    Abstract
    Scale up your cell isolation with Easy 250 EasySepâ„¢ magnet
    REVIEWS

    The Potency of Mesenchymal Stem/Stromal Cells: Does Donor Sex Matter?

    The authors summarize published studies demonstrating donor-sex-related MSC heterogeneity and emphasize the importance of disclosing donor sex as a key factor affecting MSC potency in cell therapy.
    [Stem Cell Research & Therapy]

    Full Article
    INDUSTRY AND POLICY NEWS

    Replay and MD Anderson Announce FDA Clearance of IND Application for First-in-Class PRAME-Targeted T-cell Receptor Natural Killer (TCR-NK) Cell Therapy for Hematological Malignancies

    Replay and The University of Texas MD Anderson Cancer Center announced that the FDA has issued a ‘safe to proceed’ for the Investigational New Drug (IND) application for PRAME TCR/IL-15 NK (SY-307) for relapsed/refractory myeloid malignancies.
    [Replay]

    Press Release
    FEATURED EVENT

    Cancer and Aging – The Inflammaging Connection

    May 20, 2024
    New York, New York, United States & Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Inflammation and Regeneration

    Institut Pasteur – Paris, France

    Researcher – Oncology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Staff Scientist – Extracellular Vesicle in Diabetes Treatment

    City of Hope – Duarte, California, United States

    Medicinal Chemist – Pediatric Cancers

    University of Dundee – Dundee, Scotland, United Kingdom

    Postdoctoral Scholar – Synthetic Extracellular Matrix

    University of Oregon – Eugene, Oregon, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2